Evidence map›Paper›PMID 38673853›Full record

ArticleInternational journal of molecular sciences2024

Association between

Alicja Jarosz, Anna Balcerzyk-Matić, Joanna Iwanicka, Tomasz Iwanicki, Tomasz Nowak, Karol Szyluk, Marcin Kalita, Sylwia Górczyńska-Kosiorz, Wojciech Kania, Paweł Niemiec

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Association of theInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Impact of theInternational journal of molecular sciences · 2024
    Article
  6. TheInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alicja JaroszDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.ORCID 0000-0002-8159-6437
Anna Balcerzyk-MatićDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.ORCID 0000-0002-1113-7796
Joanna IwanickaDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.ORCID 0000-0002-3609-9554
Tomasz IwanickiDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.ORCID 0000-0003-0044-3162
Tomasz NowakDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.ORCID 0000-0002-6712-5911
Karol SzylukDistrict Hospital of Orthopaedics and Trauma Surgery, Bytomska 62 Str., 41-940 Piekary Sląskie, Poland.ORCID 0000-0002-0853-9014
Marcin KalitaDistrict Hospital of Orthopaedics and Trauma Surgery, Bytomska 62 Str., 41-940 Piekary Sląskie, Poland.
Sylwia Górczyńska-KosiorzDepartment of Internal Medicine, Diabetology and Nephrology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.ORCID 0000-0001-6669-7216
Wojciech KaniaDepartment of Trauma and Orthopedic Surgery, Multidisciplinary Hospital in Jaworzno, Chełmońskiego 28 Str., 43-600 Jaworzno, Poland.
Paweł NiemiecDepartment of Biochemistry and Medical Genetics, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medykow 18 Str., 40-752 Katowice, Poland.
Medical University of Silesia · PLDemetrix (Poland) · PL

Funding

Medical University of Silesia PCN-1-096/K/1/Z
6 · The paper itself

Abstract

Individual differences in the response to platelet-rich plasma (PRP) therapy can be observed among patients. The genetic background may be the cause of this variability. The current study focused on the impact of genetic variants on the effectiveness of PRP. The aim of the present study was to analyze the impact of single nucleotide polymorphisms (SNP) of the platelet-derived growth factor receptor alpha (

Indexed as

Platelet-Rich PlasmaPolymorphism, Single NucleotideReceptor, Platelet-Derived Growth Factor alphaTendinopathyAdultAllelesFemaleGenotypeHumansMaleMiddle AgedProspective StudiesTennis ElbowTreatment OutcomeReceptor, Platelet-Derived Growth Factor alphalateral elbow tendinopathyPDGFRAplatelet-derived growth factor receptor alphaplatelet-rich plasmaPRPsingle nucleotide polymorphismsSNPtennis elbow

Identifiers

PMID38673853
PMCPMC11050239
OpenAlexW4394762128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.